Side-by-Side Comparison · 2026

CJC-1295 vs GHRP-6

CJC-1295 vs GHRP-6 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

CJC-1295
Growth Hormone

CJC-1295 is a synthetic GHRH analog with a Drug Affinity Complex (DAC) that binds circulating albumin, extending half-life from 7 minutes to approximately 6-8 days. Enables once-weekly dosing with sustained GH elevation. Phase I/II clinical research status. WADA prohibited under ...

Calculate CJC-1295 dose →
GHRP-6
Growth Hormone

GHRP-6 is the original growth hormone releasing peptide, discovered by Cyril Bowers in the 1970s through systematic study of enkephalin analogs. It was the first molecule to reveal the existence of the ghrelin receptor pathway, predating the discovery of ghrelin itself....

Calculate GHRP-6 dose →
Key Parameters
Parameter CJC-1295 GHRP-6
Category Growth Hormone Growth Hormone
Research Extensively Studied Extensively Studied
Half-Life ~6–8 days (with DAC) ~15–60 min
Typical Dose 1–2 mg 100–300 µg
Frequency Once weekly or twice weekly 2–3× daily
Route Subcutaneous Subcutaneous
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate CJC-1295 Calculate GHRP-6
Frequently Asked Questions
What is the difference between CJC-1295 and GHRP-6?
CJC-1295: CJC-1295 is a synthetic GHRH analog with a Drug Affinity Complex (DAC) that binds circulating albumin, extending half-life from 7 minutes to approximately 6-8 days. Enables once-weekly dosing with sus... GHRP-6: GHRP-6 is the original growth hormone releasing peptide, discovered by Cyril Bowers in the 1970s through systematic study of enkephalin analogs. It was the first molecule to reveal the existence of th...
Which has a longer half-life, CJC-1295 or GHRP-6?
CJC-1295 half-life: ~6–8 days (with DAC). GHRP-6 half-life: ~15–60 min.
Can you stack CJC-1295 and GHRP-6?
CJC-1295 and GHRP-6 are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.